Prospective Multi-institutional Observation Study of Charged Particle Radiation Therapy for Patients with Prostate Cancer

Prospective Multi-institutional Observation Study of Charged Particle Radiation Therapy for Patients with Prostate Cancer - Multi-institutional Study of Charged Particle Radiation Therapy for Prostate Cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000003937

Enrollment

656

Registered

2010-08-01

Start date

2010-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1)pathologically confirmed prostate cancer 2)previously untreated or receiving hormone therapy within 12 months and possible to record sufficient medical informations for analysis 3)clinical stage T1-T3N0M0 4)written informed consent

Exclusion criteria

Exclusion criteria: 1)re-elevation of serum prostate specific antigen (PSA) after start of hormone therapy 2)impossible to refer pathological specimen 3)active concurrent malignancy 4)other medical or psychological reasons for exclusion

Design outcomes

Primary

Measure	Time frame
relapse-free survival rate	—

Secondary

Measure	Time frame
overall survival rate incidence of radiation toxicity quality of life	—

Countries

Japan

Contacts

Public ContactHiroshi Tsuji

National Institute of Radiological Sciences Research Center for Charged Particle Therapy

h_tsuji@nirs.go.jp043-206-3350

Outcome results